MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemiaKirsten Canté-Barrett, Jules P.P. Meijerink|Leukemia|2016Cited by 91
Phosphoproteomic profiling of T cell acute lymphoblastic leukemia reveals targetable kinases and combination treatment strategiesValentina Cordo’, Jules P.P. Meijerink|Nature Communications|2022Cited by 31
Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemiaWillem K. Smits, Jules P.P. Meijerink|Cell Reports|2023Cited by 10